C12N 2310/15
Nucleic acids forming more than 2 strands
Official title: Nucleic acids forming more than 2 strands, e.g. TFOs
C12N2310/15 (Nucleic acids forming more than 2 strands) appears on 236 US grants and 243 published applications in this corpus.
Search patents in C12N- Granted patents
- 236
- Published applications
- 243
- Assignees
- 172
- Inventors
- 559
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 6 | 0 |
| 1996 | 11 | 0 |
| 1997 | 10 | 0 |
| 1998 | 16 | 0 |
| 1999 | 20 | 0 |
| 2000 | 18 | 0 |
| 2001 | 18 | 1 |
| 2002 | 12 | 15 |
| 2003 | 10 | 24 |
| 2004 | 8 | 12 |
| 2005 | 4 | 15 |
| 2006 | 5 | 7 |
| 2007 | 7 | 4 |
| 2008 | 7 | 5 |
| 2009 | 6 | 19 |
| 2010 | 4 | 7 |
| 2011 | 7 | 12 |
| 2012 | 5 | 6 |
| 2013 | 2 | 3 |
| 2014 | 6 | 4 |
| 2015 | 4 | 7 |
| 2016 | 1 | 7 |
| 2017 | 6 | 9 |
| 2018 | 6 | 12 |
| 2019 | 5 | 4 |
| 2020 | 5 | 9 |
| 2021 | 4 | 14 |
| 2022 | 2 | 15 |
| 2023 | 4 | 7 |
| 2024 | 5 | 11 |
| 2025 | 9 | 7 |
| 2026 | 2 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Targeting gene amplification in cancer using triplex formation as a therapeutic strategy18 Aug 2026US 12,709,645 B2Yale University
- Nucleic acid mazzocchio and methods of making and use thereof3 Mar 2026US 12,564,637 B2The University of Hong Kong
- Compositions and methods for treating sickle cell disease16 Dec 2025US 12,496,357 B2Yale University
- Compositions and methods for detecting viral nucleic acids9 Dec 2025US 12,492,424 B2Arizona Board of Regents on behalf of Arizona State University
- Artificial nucleic acid, production method therefor, and use thereof23 Sep 2025US 12,421,272 B2Sysmex Corporation
- Targeting gene amplification in cancer using triplex formation as a therapeutic strategy10 Sep 2026US 2026/0265407 A1Yale University
- Catalytic nucleic acid-based genetic engineering method27 Aug 2026US 2026/0250677 A1Board of Regents, The University of Texas System
- Synthetic single-stranded dna molecules and methods of producing and using the same16 Jul 2026US 2026/0199386 A1Generation Bio Co.
- Synthetic triplex peptide nucleic acid-based inhibitors for cancer therapy7 May 2026US 2026/0125428 A1University of Connecticut
- Synthetic triplex peptide nucleic acid-based inhibitors for cancer therapy2 Apr 2026US 2026/0092085 A1Beth Israel Deaconess Medical Center, Inc.
Most cited
By later US patents
- Peptide nucleic acids763US 5,539,082 A1996
- Oligonucleotides with inverted polarity531US 5,399,676 AGilead Sciences, Inc. · 1995
- Method of expanded porphyrin-oligonucleotide conjugate synthesis325US 5,565,552 ABoard of Regents, Univ. of Texas Sys. · 1996
- In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom267US 5,624,803 AThe Regents of the University of California · 1997
- Oligonucleotides with inverted polarity255US 5,527,899 AGilead Sciences, Inc. · 1996